CCND1 and expression of CyclinD1 were evaluated by fluorescence in situ hybridization and immunohistochemistry on patient tumor biopsies obtained from node-positive urothelial bladder cancers. This evidence concerns the gene CCND1 and bladder transitional cell carcinoma.